Pursglove Geordan Garrett sold LIXT
April 15, 2026 · Form 4 insider transaction
Pursglove Geordan Garrett sold 350,000 shares of LIXT, a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
On April 15, 2026, the Issuer canceled, pursuant to that certain Stock Option Cancellation Agreement dated April 15, 2026 between the Issuer and the Reporting Person, the 350,000 options (the "Options") granted to the Reporting Person on July 3, 2025. In exchange for the Options, the Reporting Person received 350,000 restricted share units ("RSUs"). The RSUs were granted pursuant to the applicable award agreement dated April 15, 2026 and the Lixte Biotechnology Holdings, Inc. 2020 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon vesting, subject to continued service. The 350,000 RSUs vest immediately upon grant.; The canceled Options provided for vesting 50% on the effective date, 25% on September 30,2025 and 25% on December 31,2025.